BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2016 3:05:00 PM | Browse: 1148 | Download: 1548
Publication Name World Journal of Respirology
Manuscript ID 22849
Country/Territory United States
Received
2015-09-28 17:13
Peer-Review Started
2015-09-28 20:42
To Make the First Decision
2015-11-24 14:53
Return for Revision
2015-11-30 15:27
Revised
Second Decision
2016-03-07 15:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-03-16 16:10
Articles in Press
2016-03-16 16:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-21 17:54
Publish the Manuscript Online
2016-03-25 15:05
ISSN 2218-6255 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Respiratory System
Manuscript Type Review
Article Title Lung cancer screening: Should we be excluding people with previous malignancy?
Manuscript Source Invited Manuscript
All Author List Cherie P Erkmen, Larry R Kaiser and Ashley L Ehret
Funding Agency and Grant Number
Corresponding Author Cherie P Erkmen, MD, Associate Professor of Surgery, Director of The Temple-Fox Chase Lung Cancer Screening Program, Department of Thoracic Medicine and Surgery, Temple University Health System, 3401 North Broad Street, Philadelphia, PA 19140, United States. cherie.p.erkmen@tuhs.temple.edu
Key Words Lung cancer screening; Criteria; Previous malignancy; Antecedent malignancy; Lung metastasis; Guidelines; Head and neck cancer; Lung cancer; Low dose computed tomography; Gastric cancer; Breast cancer; Colorectal cancer; Lymphoma; Esophageal cancer
Core Tip Most lung cancer screening trials, including the National Lung Screening Trial, exclude those with a history of a previous malignancy as it may introduce confounding factors that influence survival. However, people with previous malignancy may benefit from the discovery of treatable lung cancer as well as treatable metastasis. In this review, we summarize the consideration that studies and national guidelines give in regards to lung cancer screening in patients with previous malignancy. Furthermore, we address the implications of lung cancer screening in the setting of specific malignancies, namely lung, head and neck, esophageal, gastric, breast, colorectal cancer and lymphoma.
Publish Date 2016-03-25 15:05
Citation Erkmen CP, Kaiser LR, Ehret AL. Lung cancer screening: Should we be excluding people with previous malignancy? World J Respirol 2016; 6(1): 1-13
URL http://www.wjgnet.com/2218-6255/full/v6/i1/1.htm
DOI http://dx.doi.org/10.5320/wjr.v6.i1.1
Full Article (PDF) WJR-6-1.pdf
Full Article (Word) WJR-6-1.doc
Manuscript File 22849-Review.docx
Answering Reviewers 22849-Answering reviewers.pdf
Audio Core Tip 22849-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 22849-Conflict-of-interest statement.pdf
Copyright License Agreement 22849-Copyright assignment.pdf
Peer-review Report 22849-Peer-review(s).pdf
Scientific Misconduct Check 22849-Scientific misconduct check.pdf
Scientific Editor Work List 22849-Scientific editor work list.pdf